Change vs. the prior quarter call: Q2 guidance was raised to $490 million-$500 million revenue and $66 million-$78 million adjusted EBITDA; in Q3, management raised those ranges to $520 million-$530 ...
UHN Foundation proudly announces a landmark $35 million gift from Toronto's Ajmera family, raising their cumulative giving to $62 million and establishing the Ajmera Transplant Institute at University ...
The first-in-human combined bladder and kidney transplant, reported in June 2026, restored spontaneous voiding and stable ...
Researchers are exploring new options for patients with relapsed or refractory hairy cell leukemia, including chimeric ...
Cellular reprogramming enables scientists to reset the biological clock of mature human cells without stripping away their ...
Medical device firm Therakos received EU Medical Device Regulation approval for its THERAKOS CELLEX Photopheresis System to ...
CareDx, Inc. highlighted data featuring AlloSure® Kidney donor-derived cell-free DNA (dd-cfDNA) being presented at the American Society of Nephrology (ASN) Kidney Week 2026, taking place October 22?25 ...
In an independent randomized trial, AlloSure-based monitoring demonstrates a significant reduction in kidney transplant biopsies while maintaining similar clinical outcomes A multinational study ...
An inspirational teenager who ‘defied the odds’ tragically died as a result of his life-saving surgery. William Simpson, aged ...
In the nearly five years since the first genetically modified pig heart was transplanted into a living heart failure patient at the University of ...
A new clinical trial is investigating tegoprubart with islet cell transplants in people with type 1 diabetes and kidney disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results